about
Human epidermal growth factor receptor 2 testing in gastric cancer: recommendations of an Asia-Pacific task forceManagement and outcome of gastric carcinoma in Zaria, Nigeria.Efficacy of adjuvant chemotherapy combined with immunotherapy with cytokine-induced killer cells for gastric cancer after d2 gastrectomy.Clinical Relevance of the Tumor Location-Modified Lauren Classification System of Gastric Cancer.MHC I-related chain a expression in gastric carcinoma and the efficacy of immunotherapy with cytokine-induced killer cells.Development and external validation of preoperative risk models for operative morbidities after total gastrectomy using a Japanese web-based nationwide registry.(18)F-FDG PET/CT of advanced gastric carcinoma and association of HER2 expression with standardized uptake value.Evaluation of recurrence in gastric carcinoma: Comparison of contrast-enhanced computed tomography and positron emission tomography/computed tomography.B7-H3 promotes gastric cancer cell migration and invasion.Outcomes of radiation therapy for resectable M0 gastric cancer.Screening and Identification of Peptides Specifically Targeted to Gastric Cancer Cells from a Phage Display Peptide LibraryClinical significance of circulating tumor cells in blood from patients with gastric cancer.The composition and variation of the BCR CDR3s in gastric cancer.Adjuvant chemotherapy with S-1 plus oxaliplatin improves survival of patients with gastric cancer after D2 gastrectomy: A multicenter propensity score-matched studyEfficacy and safety of trastuzumab as maintenance or palliative therapy in advanced HER2-positive gastric cancerIdentification of a high-risk subtype of intestinal-type Japanese gastric cancer by quantitative measurement of the luminal tumor proportion
P2860
Q34559419-91FCAFEC-C121-4498-954A-FDA38A08FB70Q35680094-BBE0BEBE-250A-4600-9A0C-58DB03611340Q35870886-0532E4D6-7F6C-46B6-BD4D-93AA96D3879EQ36158080-B9721891-55B5-48EF-9254-CA0FF48B1AFAQ36309435-45906853-2CBC-4AE0-89C9-064905472C5DQ40297975-7DC1E005-310A-4D01-9997-1EB2E57CE05DQ41835781-F453FC10-BB8F-4C7F-BF67-AB5A1A82ED12Q42695233-D916D840-2454-4A31-9F94-B9E207AF920AQ42700893-27D957AB-7490-4ADD-93B4-6EAF89F83102Q49164896-6B934866-6B5E-4DE3-9D02-FC60DCA25AAEQ52564277-5FDB9B7A-0B52-4248-B78B-A3E91F835907Q55096369-A6218D03-959F-446A-85B1-B04E91F2055BQ55175564-9BE6B940-6519-4983-A9A0-73A4559AB340Q57069558-0D41FF6F-81DD-4E73-A799-5307E8478FFDQ57072196-FC140FA0-D4F2-4892-9682-381BBF65D74DQ58692213-E6E434C7-B3B4-4868-91D1-31A171F40557
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current approaches to gastric cancer in Korea.
@en
Current approaches to gastric cancer in Korea.
@nl
type
label
Current approaches to gastric cancer in Korea.
@en
Current approaches to gastric cancer in Korea.
@nl
prefLabel
Current approaches to gastric cancer in Korea.
@en
Current approaches to gastric cancer in Korea.
@nl
P2860
P1476
Current approaches to gastric cancer in Korea
@en
P2093
Joong-Min Park
Yeul Hong Kim
P2860
P304
P577
2008-05-01T00:00:00Z